2023 Healthcare Prescription Safety 
European Pharmaceutical Review
JANUARY 25, 2024
Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. percent as EU average with some Member States as high as 25 percent).
PM360
OCTOBER 13, 2023
And while they’re excited about the drugs’ results and limited side effects now, many also noted concerns about the lack of safety data and long-term risks. It seems fewer doctors guide patients to intermittent fasting (62%) or anaerobic exercise (55%) than to prescription weight loss drugs and aerobic exercise.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
SEPTEMBER 21, 2023
Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.
Clarivate
OCTOBER 25, 2023
While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. Humira, the long-running blockbuster autoimmune drug, was not eligible for negotiations since it will have nine biosimilars on the market by the end of 2023. With 27.5%
PM360
AUGUST 9, 2022
One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Unlike other formulary optimization solutions, Levrx delivers plan-specific and real-time prescription insights. billion in 2030 at a CAGR of 9.2%.
PM360
DECEMBER 20, 2023
With its rapidly evolving healthcare system, limited transparency of public information, and language barriers, China has never proven to be an easy market for overseas pharmaceutical companies to enter. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1% in the U.S.
PM360
OCTOBER 13, 2023
Will Big Tech’s moves within healthcare force the industry to change how it operates? Casey Cronin Life sciences marketers have a unique opportunity to connect with target audiences on an individual level and foster brand safety through AI advancement. Here are the best responses. to inform HCP engagement strategy.
Expert insights. Personalized for you.
81 
Let's personalize your content